Novartis: all 3,900 studies
Page 3 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple SclerosisRecruitingNCT05344469
- A Post Marketing Surveillance on Piqray in KoreaRecruitingNCT05293470
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With AsthmaRecruitingNCT05222529Phase 2
- Managed Access Programs for LNP023, IptacopanAvailableNCT05222412
- Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous UrticariaAvailableNCT05170724
- Managed Access Programs for LEE011, RibociclibAvailableNCT05038631
- A Study of 177Lu-FAP-2286 in Advanced Solid TumorsRecruitingNCT04939610Phase 1/2
- Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With MayzentRecruitingNCT04933552
- Asciminib Roll-over StudyRecruitingNCT04877522Phase 4
- Managed Access Programs for ETB115, EltrombopagAvailableNCT04837703
- Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.RecruitingNCT04817618Phase 3
- Managed Access Programs for INC424, RuxolitinibAvailableNCT04745637
- Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab StudyRecruitingNCT04657822Phase 4
- Secukinumab Open Label Roll-over Extension ProtocolRecruitingNCT04638647Phase 4
- A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA NephropathyRecruitingNCT04557462Phase 3
- Managed Access Programs for ABL001, AsciminibAvailableNCT04360005
- Lamprene Multiple Patient ProgramAvailableNCT04334070
- Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)RecruitingNCT04174157
- A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasRecruitingNCT04104776Phase 1/2
- Study of Out of Specification for TisagenlecleucelRecruitingNCT04094311Phase 3
- Managed Access Programs for BYL719, AlpelisibAvailableNCT04085653
- Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGNRecruitingNCT03955445Phase 3
- Managed Access Programs for SEG101, CrizanlizumabAvailableNCT03720626
- Managed Access Programs for CTL019, TisagenlecleucelAvailableNCT03601442
- Dabrafenib and/or Trametinib Rollover StudyRecruitingNCT03340506Phase 4
- CAR-T Long Term Follow Up (LTFU) StudyRecruitingNCT02445222Phase 3
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B2)CompletedNCT07235033Phase 2Results posted
- A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRPCompletedNCT06362759Phase 2Results posted
- A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in JapanCompletedNCT06240741Phase 3Results posted
- A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 StudyCompletedNCT06149104Phase 3Results posted
- A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart FailureTerminatedNCT06142383Phase 2Results posted
- A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)CompletedNCT06097663Phase 2Results posted
- A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Elevated hsCRPCompletedNCT06031844Phase 2Results posted
- Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.CompletedNCT05888103Phase 3Results posted
- Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum MalariaCompletedNCT05842954Phase 3Results posted
- Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA NephropathyCompletedNCT05834738Phase 2Results posted
- Safety and Efficacy of RHH646 for Knee OsteoarthritisCompletedNCT05816395Phase 2Results posted
- A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks.CompletedNCT05795153Phase 3Results posted
- Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension ParticipantsTerminatedNCT05764265Phase 2Results posted
- Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.CompletedNCT05763875Phase 3Results posted
- Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff TendinopathyTerminatedNCT05758415Phase 3Results posted
- A Randomized, Open, Parallel, Controlled, Multi-center, Interventional, Cross-sectional Study to Evaluate the Detection Rate of Psoriatic Arthritis in Korean Moderate-to-severe Psoriasis Patients, With or Without Active Screening for Arthritis in Psoriasis (ASAP Study)CompletedNCT05758402Not applicableResults posted
- Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff TendinopathyTerminatedNCT05722522Phase 3Results posted
- Long-term Extension Study of Ligelizumab in Food AllergyTerminatedNCT05678959Phase 3Results posted
- Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine TreatmentCompletedNCT05631795Phase 4Results posted
- Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.CompletedNCT05630001Phase 3Results posted
- Study of Efficacy and Safety of AIN457/Secukinumab in Patients With Rotator Cuff TendinopathyCompletedNCT05569174Phase 3Results posted
- An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.CompletedNCT05562934Phase 2Results posted
- A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery.TerminatedNCT05524051Phase 2Results posted
- Pharmacokinetics and Safety of TIN816 in Patients With Sepsis-associated Acute Kidney InjuryCompletedNCT05507437Phase 2Results posted
- To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPFTerminatedNCT05497284Phase 2Results posted
- A Proof-of-concept Study to Examine QUC398 in Participants With Knee OATerminatedNCT05462990Phase 2Results posted
- A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)Active, not recruitingNCT05456191Phase 3Results posted
- Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD)CompletedNCT05454410Phase 2Results posted
- A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell TransplantTerminatedNCT05447663Phase 1/2Results posted
- Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.Active, not recruitingNCT05445843Phase 2Results posted
- Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to PeanutsCompletedNCT05432388Phase 2Results posted
- A Study of RGLS8429 in Healthy VolunteersCompletedNCT05429073Phase 1Results posted
- Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or RisdiplamCompletedNCT05386680Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)CompletedNCT05358717Phase 2Results posted
- A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of Weekly Lipoprotein Apheresis Sessions in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease in GermanyCompletedNCT05305664Phase 3Results posted
- Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Vial KitCompletedNCT05282004Phase 3Results posted
- Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)CompletedNCT05269966Phase 4Results posted
- A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast CancerCompletedNCT05258747Phase 1Results posted
- Open-label Extension Study of Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Lupus NephritisTerminatedNCT05232864Phase 3Results posted
- Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in ChinaCompletedNCT05199571Phase 4Results posted
- Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DMTerminatedNCT05199090Phase 2Results posted
- Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With HypercholesterolemiaCompletedNCT05192941Phase 4Results posted
- Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled SyringeCompletedNCT05161806Phase 3Results posted
- Study of Efficacy and Safety of LTP001 in Pulmonary Arterial HypertensionTerminatedNCT05135000Phase 2Results posted
- A Dose Range Finding Study With Open-Label Extension to Evaluate the Safety of Oral LMI070/Branaplam in Early Manifest Huntington's DiseaseTerminatedNCT05111249Phase 2Results posted
- Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.CompletedNCT05110196Phase 4Results posted
- Efficacy and Safety of Intrathecal OAV101 (AVXS-101) in Pediatric Patients With Type 2 Spinal Muscular Atrophy (SMA)CompletedNCT05089656Phase 3Results posted
- Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological DisordersTerminatedNCT05086744Phase 2Results posted
- Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls.CompletedNCT05084638Phase 4Results posted
- Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) (OFELIA)CompletedNCT05073133Phase 4Results posted
- A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistaminesCompletedNCT05048342Phase 3Results posted
- Study of Efficacy and Safety of ABO809 in Healthy ParticipantsCompletedNCT05036668Phase 1Results posted
- A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistaminesCompletedNCT05032157Phase 3Results posted
- A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 AntihistaminesCompletedNCT05030311Phase 3Results posted
- Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) PatientsCompletedNCT05027269Phase 1/2Results posted
- Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- AntihistaminesTerminatedNCT05024058Phase 3Results posted
- A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)TerminatedNCT04988087Phase 2Results posted
- Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut AllergyTerminatedNCT04984876Phase 3Results posted
- A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPActive, not recruitingNCT04971226Phase 3Results posted
- Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRCTerminatedNCT04952753Phase 2Results posted
- Asciminib Treatment Optimization in ≥ 3rd Line CML-CPCompletedNCT04948333Phase 3Results posted
- Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid CancerActive, not recruitingNCT04940052Phase 3Results posted
- Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2CompletedNCT04935359Phase 3Results posted
- A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE)CompletedNCT04929249Phase 3Results posted
- Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLCTerminatedNCT04926831Phase 2Results posted
- Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and FulvestrantTerminatedNCT04899349Phase 2Results posted
- Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee OsteoarthritisCompletedNCT04886258Phase 2Results posted
- STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDSTerminatedNCT04878432Phase 2Results posted
- A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With OfatumumabTerminatedNCT04878211Phase 4Results posted
- Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary SyndromeCompletedNCT04873934Phase 3Results posted
- Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With OfatumumabCompletedNCT04869358Phase 4Results posted
- Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)CompletedNCT04868968Phase 2Results posted
- Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With Neovascular Age-related Macular DegenerationCompletedNCT04864834Phase 3Results posted
- Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee OsteoarthritisTerminatedNCT04864392Phase 2Results posted